Skip to main content
Top
Published in: Journal of General Internal Medicine 4/2010

01-04-2010 | Editorial

Primary Non-adherence of Medications: lifting the veil on prescription-filling behaviors

Authors: Matthew D. Solomon, MD, PhD, Sumit R. Majumdar, MD, MPH, FRCPC, FACP

Published in: Journal of General Internal Medicine | Issue 4/2010

Login to get access

Excerpt

Economists say that consumers “vote with their feet”. That is, in order to understand human behavior, we can interpret people's underlying preferences by observing their choices. Unfortunately, in much of the social sciences, researchers are limited in their ability to directly observe people’s choices. This is particularly true when studying the problem of medication adherence. Medication “adherence” is defined as the degree of patient compliance with providers’ recommendations about the daily timing, dosage, and frequency of medication use. This differs from “persistence,” which refers to whether patients continue a treatment for the prescribed duration. Both are difficult to study. Aside from watching patients drop pills into their mouths and swallow them every day (which is clearly infeasible except for extreme circumstances such as directly observed treatment for multidrug resistant tuberculosis or HIV) researchers are left to examine surrogate measures of adherence behaviors. …
Literature
1.
go back to reference Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Int Med. 2006;166:1836–41.CrossRef Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Int Med. 2006;166:1836–41.CrossRef
2.
go back to reference Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, Johnson JA. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;332:15–9.CrossRef Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, Johnson JA. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;332:15–9.CrossRef
3.
go back to reference McCombs JS, Nichol MB, Newman CM, Sclar DA. The costs of interrupting antihypertensive drug therapy in a Medicaid population. Med Care. 1994;32(3):214–26.CrossRefPubMed McCombs JS, Nichol MB, Newman CM, Sclar DA. The costs of interrupting antihypertensive drug therapy in a Medicaid population. Med Care. 1994;32(3):214–26.CrossRefPubMed
4.
go back to reference Goldman DP, Joyce GF, Zheng Y. Prescription Drug Cost Sharing: Associations With Medication and Medical Utilization and Spending and Health. JAMA. 2007;298:61–9.CrossRefPubMed Goldman DP, Joyce GF, Zheng Y. Prescription Drug Cost Sharing: Associations With Medication and Medical Utilization and Spending and Health. JAMA. 2007;298:61–9.CrossRefPubMed
5.
go back to reference Safran DG, Neuman P, Schoen C, Kitchman MS, Wilson IB, Cooper B, Li A, Chang H, Rogers WH. Prescription Drug Coverage And Seniors: Findings From A 2003 National Survey. Health Aff. 2005 Jan-Jun;Suppl Web Exclusives:W5-152-W5-166. Safran DG, Neuman P, Schoen C, Kitchman MS, Wilson IB, Cooper B, Li A, Chang H, Rogers WH. Prescription Drug Coverage And Seniors: Findings From A 2003 National Survey. Health Aff. 2005 Jan-Jun;Suppl Web Exclusives:W5-152-W5-166.
6.
go back to reference Natarajan S, Nietert PJ. National trends in screening, prevalence, and treatment of cardiovascular risk factors. Prev Med. 2003;36(4):389–97.CrossRefPubMed Natarajan S, Nietert PJ. National trends in screening, prevalence, and treatment of cardiovascular risk factors. Prev Med. 2003;36(4):389–97.CrossRefPubMed
7.
go back to reference Solomon MD, Goldman DP, Joyce GF, Escarce JJ. Cost sharing and the initiation of drug therapy for the chronically ill. Arch Intern Med. 2009;169(8):740–8.CrossRefPubMed Solomon MD, Goldman DP, Joyce GF, Escarce JJ. Cost sharing and the initiation of drug therapy for the chronically ill. Arch Intern Med. 2009;169(8):740–8.CrossRefPubMed
8.
go back to reference Gibson TB, Mark TL, McGuigan KA, Axelsen K, Wang S. The effects of prescription drug copayments on statin adherence. Am J Manag Care. 2006;12:509–17.PubMed Gibson TB, Mark TL, McGuigan KA, Axelsen K, Wang S. The effects of prescription drug copayments on statin adherence. Am J Manag Care. 2006;12:509–17.PubMed
9.
go back to reference Jackevicius CA, Li P, Tu JV. Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction. Circulation. 2008;117(8):1028–36.CrossRefPubMed Jackevicius CA, Li P, Tu JV. Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction. Circulation. 2008;117(8):1028–36.CrossRefPubMed
10.
go back to reference Fischer MA, Stedman MR, Li J, Vogeli C, Shrank WH, Brookhart MA, Weissman JS. Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med. 2010; XXXXXX\. Fischer MA, Stedman MR, Li J, Vogeli C, Shrank WH, Brookhart MA, Weissman JS. Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med. 2010; XXXXXX\.
11.
go back to reference Bell DS, Marken RS, Meili RC, Wang CJ, Rosen M, Brook RH. RAND Electronic Prescribing Expert Advisory Panel. Recommendations for comparing electronic prescribing systems: results of an expert consensus panel. Health Aff (Millwood). 2004 Jan-Jun;Suppl Web Exclusives:W4-305–17. Bell DS, Marken RS, Meili RC, Wang CJ, Rosen M, Brook RH. RAND Electronic Prescribing Expert Advisory Panel. Recommendations for comparing electronic prescribing systems: results of an expert consensus panel. Health Aff (Millwood). 2004 Jan-Jun;Suppl Web Exclusives:W4-305–17.
12.
go back to reference Gandhi TK, Weingart SN, Seger AC, Borus J, Burdick E, Poon EG, Leape LL, Bates DW. Outpatient prescribing errors and the impact of computerized prescribing. J Gen Intern Med. 2005;20(9):837–41.CrossRefPubMed Gandhi TK, Weingart SN, Seger AC, Borus J, Burdick E, Poon EG, Leape LL, Bates DW. Outpatient prescribing errors and the impact of computerized prescribing. J Gen Intern Med. 2005;20(9):837–41.CrossRefPubMed
Metadata
Title
Primary Non-adherence of Medications: lifting the veil on prescription-filling behaviors
Authors
Matthew D. Solomon, MD, PhD
Sumit R. Majumdar, MD, MPH, FRCPC, FACP
Publication date
01-04-2010
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 4/2010
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-010-1286-0

Other articles of this Issue 4/2010

Journal of General Internal Medicine 4/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine